Journey Colab Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Out of Business

Journey Colab General Information

Description

Operator of a therapeutics and clinical application company intended to build a model of addiction care by leveraging the potential of new psychedelic therapeutics. The company uses the compound synthetic mescaline hydrochloride for patients with alcohol-use disorder, enabling medical professionals to offer healing support and medication for mental illnesses.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 548 Market Street
  • Suite 85082
  • San Francisco, CA 94104
  • United States
+1 (415)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • 548 Market Street
  • Suite 85082
  • San Francisco, CA 94104
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Journey Colab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 06-Jan-2025 Completed Out of Business
3. Early Stage VC 17-Aug-2022 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 01-Nov-2021 $15.7M $18.7M Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 26-Oct-2020 $3M $3M Completed Startup
To view Journey Colab’s complete valuation and funding history, request access »

Journey Colab Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2
Series A1
Series A 1,754,488 $0.000010 $1.71 $1.71 1x $1.71 11.25%
To view Journey Colab’s complete cap table history, request access »

Journey Colab Patents

Journey Colab Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250162980-A1 Methods for preparing mescaline Pending 25-Feb-2022
WO-2023164178-A2 Methods for preparing mescaline Inactive 25-Feb-2022
WO-2023164178-A3 Methods for preparing mescaline Inactive 25-Feb-2022
US-20250064782-A1 Methods of treating substance use disorders using 5-meo-dmt Pending 17-Dec-2021
WO-2023114557-A2 Methods of treating substance use disorders using 5-meo-dmt Inactive 17-Dec-2021 A61K31/4045
To view Journey Colab’s complete patent history, request access »

Journey Colab Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Journey Colab FAQs

  • When was Journey Colab founded?

    Journey Colab was founded in 2020.

  • Where is Journey Colab headquartered?

    Journey Colab is headquartered in San Francisco, CA.

  • What is the size of Journey Colab?

    Journey Colab has 4 total employees.

  • What industry is Journey Colab in?

    Journey Colab’s primary industry is Drug Discovery.

  • Is Journey Colab a private or public company?

    Journey Colab is a Private company.

  • What is Journey Colab’s current revenue?

    The current revenue for Journey Colab is .

  • How much funding has Journey Colab raised over time?

    Journey Colab has raised $30.7M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process